Riku Nagao

Kashiwa, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.

Geriatric nutritional risk index for the prediction of venous thrombotic events in multiple myeloma.

Journal: International journal of clinical oncology

Published: April 11, 2026

Geriatric nutritional risk index predicts 10-year survival in patients with multiple myeloma.

Geriatric nutritional risk index predicts 10-year survival in patients with multiple myeloma.

Journal: Japanese journal of clinical oncology

Published: December 16, 2025

Impact of diagnosis-to-treatment interval in relapsed or refractory diffuse large B-cell lymphoma.

Impact of diagnosis-to-treatment interval in relapsed or refractory diffuse large B-cell lymphoma.

Journal: International journal of hematology

Published: August 09, 2025

Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma.

Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma.

Journal: Cancers

Published: November 27, 2024

Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients.

Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients.

Journal: International journal of hematology

Published: September 06, 2024

Thrombocytopenia With High C-reactive Protein in Myeloma Patients Treated With Proteasome Inhibitor and/or Immunomodulatory Drugs.

Thrombocytopenia With High C-reactive Protein in Myeloma Patients Treated With Proteasome Inhibitor and/or Immunomodulatory Drugs.

Journal: Cancer diagnosis & prognosis

Published: August 15, 2024

Safety and efficacy of automatic subcutaneous injection of daratumumab via an infusion pump.

Safety and efficacy of automatic subcutaneous injection of daratumumab via an infusion pump.

Journal: International journal of hematology

Published: August 06, 2024

Contribution of post-transplantation therapy to sustained MRD negativity in multiple myeloma: a retrospective analysis.

Contribution of post-transplantation therapy to sustained MRD negativity in multiple myeloma: a retrospective analysis.

Journal: International journal of hematology

Published: July 25, 2023

Clinical significance of the lymphocyte-to-monocyte ratio in multiple myeloma patients with negative minimal residual disease: a single-center retrospective analysis.

Clinical significance of the lymphocyte-to-monocyte ratio in multiple myeloma patients with negative minimal residual disease: a single-center retrospective analysis.

Journal: International journal of hematology

Published: May 26, 2021

All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis

All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: November 07, 2019

Successful treatment with preceding low-intensity chemotherapy in a primary mediastinal large B cell lymphoma patient diagnosed at 11 weeks of pregnancy

Successful treatment with preceding low-intensity chemotherapy in a primary mediastinal large B cell lymphoma patient diagnosed at 11 weeks of pregnancy

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 08, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026